Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, reflecting a minor update to the page metadata. The change represents an internal update to the ClinicalTrials.gov entry rather than a modification to the study content or results.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page's template or backend. No study content or user-facing information was changed.SummaryDifference0.0%

- Check29 days agoChange DetectedNo additions or deletions are listed. The supplied change data contains no textual changes for this page.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded a revision tag for v3.5.3, updating the page's revision history. The previous revision v3.5.2 is no longer the current tag, signaling a minor update to the page metadata.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded revision label v3.5.2. Removed revision label v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.